Schrodinger, Inc. (SDGR) stock
SDGRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 12/3076% above fair value
$30.85−0.67 (-2.13%)
Close on Nov 12, 2026Market cap $2.31BP/E –Yield –
Schrodinger cash
Cash and short-term investments held at the end of each period.
Schrodinger's cash was $366.36M at Sep 30, 2026. For fiscal 2025 it was $395.46M, up 7.6% from the year before. The highest annual figure on record is $643.19M in fiscal 2020.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $395.46M | +7.6% |
| FY2024 | Dec 31, 2024 | $367.46M | -21.6% |
| FY2023 | Dec 31, 2023 | $468.75M | +2.7% |
| FY2022 | Dec 31, 2022 | $456.33M | -21.3% |
| FY2021 | Dec 31, 2021 | $579.48M | -9.9% |
| FY2020 | Dec 31, 2020 | $643.19M | +645.0% |
| FY2019 | Dec 31, 2019 | $86.33M | +11.1% |
| FY2018 | Dec 31, 2018 | $77.72M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $366.36M | -8.6% |
| Q2 FY2026 | Jun 30, 2026 | $413.74M | -10.5% |
| Q1 FY2026 | Mar 31, 2026 | $398.96M | -22.1% |
| Q4 FY2025 | Dec 31, 2025 | $395.46M | +7.6% |
| Q3 FY2025 | Sep 30, 2025 | $400.99M | +0.6% |
| Q2 FY2025 | Jun 30, 2025 | $462.26M | +21.2% |
| Q1 FY2025 | Mar 31, 2025 | $512.06M | +17.5% |
| Q4 FY2024 | Dec 31, 2024 | $367.46M | -21.6% |
| Q3 FY2024 | Sep 30, 2024 | $398.44M | -20.7% |
| Q2 FY2024 | Jun 30, 2024 | $381.52M | -31.1% |
| Q1 FY2024 | Mar 31, 2024 | $435.72M | -18.1% |
| Q4 FY2023 | Dec 31, 2023 | $468.75M | +2.7% |
| Q3 FY2023 | Sep 30, 2023 | $502.51M | +4.8% |
| Q2 FY2023 | Jun 30, 2023 | $553.73M | +7.9% |
| Q1 FY2023 | Mar 31, 2023 | $532.17M | +0.6% |
| Q4 FY2022 | Dec 31, 2022 | $456.33M | -21.3% |
| Q3 FY2022 | Sep 30, 2022 | $479.36M | -20.1% |
| Q2 FY2022 | Jun 30, 2022 | $513.07M | -16.8% |
| Q1 FY2022 | Mar 31, 2022 | $529.04M | -18.5% |
| Q4 FY2021 | Dec 31, 2021 | $579.48M | -9.9% |
| Q3 FY2021 | Sep 30, 2021 | $600.19M | +0.1% |
| Q2 FY2021 | Jun 30, 2021 | $616.59M | +116.7% |
| Q1 FY2021 | Mar 31, 2021 | $648.99M | +124.8% |
| Q4 FY2020 | Dec 31, 2020 | $643.19M | +645.0% |
| Q3 FY2020 | Sep 30, 2020 | $599.48M | +1711.7% |
| Q2 FY2020 | Jun 30, 2020 | $284.53M | +540.0% |
| Q1 FY2020 | Mar 31, 2020 | $288.75M | +364.4% |
| Q4 FY2019 | Dec 31, 2019 | $86.33M | +11.1% |
| Q3 FY2019 | Sep 30, 2019 | $33.09M | – |
| Q2 FY2019 | Jun 30, 2019 | $44.45M | – |
| Q1 FY2019 | Mar 31, 2019 | $62.18M | – |
| Q4 FY2018 | Dec 31, 2018 | $77.72M | – |
See a number that looks wrong?